# Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

> **NCT02025023** · PHASE3 · RECRUITING · sponsor: **University of Washington** · enrollment: 120 (estimated)

## Conditions studied

- Chalazion

## Interventions

- **DRUG:** 5-fluorouracil Injection
- **DRUG:** Triamcinolone Acetonide
- **PROCEDURE:** Incision and Curettage
- **DRUG:** Triamcinolone Acetonide/5-fluorouracil mixture

## Key facts

- **NCT ID:** NCT02025023
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2013-12
- **Primary completion:** 2025-07
- **Final completion:** 2026-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2020-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02025023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02025023, "Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02025023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*